Neuropeptides. Mediators of inflammation and tissue repair?

Archives of Surgery

Volumn 133, Issue 10, 1998, Pages 1107-1116

  Schäffer, Michael ^a   Beiter, Thomas ^a   Becker, Horst Dieter ^a   Hunt, Thomas K ^b,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; HISTAMINE; NERVE GROWTH FACTOR; NEUROPEPTIDE; NEUROPEPTIDE Y; OPIATE AGONIST; POTASSIUM; PROSTAGLANDIN DERIVATIVE; SEROTONIN; SOMATOSTATIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

CELL INTERACTION; CELL PROLIFERATION; ENZYME METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LYMPHOCYTE ACTIVATION; NEUROMODULATION; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TISSUE INJURY;

CALCITONIN GENE-RELATED PEPTIDE; CELL DIVISION; IMMUNE SYSTEM; INFLAMMATION; MACROPHAGES; MAST CELLS; MONOCYTES; NEUROPEPTIDES; PERIPHERAL NERVOUS SYSTEM; SUBSTANCE P; T-LYMPHOCYTES; WOUND HEALING;

EID: 0031755682     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.133.10.1107     Document Type: Review

References (170)

1. Barbul A. Immune aspects of wound repair. Clin Plast Surg. 1990;17:433-442.
2. Cioffi WG, Burleson DG, Pruitt BA. Leukocyte responses to injury. Arch Surg. 1993;128:1260-1267.
3. Guirao X, Lowry SF. Biologic control of injury and inflammation: much more than too little or too late. World J Surg. 1996;20:437-446.
4. Payan DG. Neuropeptides and inflammation: the role of substance P. Annu Rev Med. 1989;40:341-352.
5. Hökfelt T, Johansson O, Ljungdahl A, Lundberg JM, Schultzberg M. Peptidergic neurones. Nature. 1980;284:515-521.
6. Jessell TM, Kelly DD. Pain and analgesia. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of Neural Science. New York, NY: Elsevier Science Inc; 1991:385-399.
7. Felten DL, Felten SY, Bellinger DL, et al. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol Rev. 1987;100:225-258.
8. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience. 1988;24:739-768.
9. Hökfelt T, Schaible HG, Schmidt RF, eds. Neuropeptides. Nociception and Pain. Weinheim, Germany: Chapman & Hall; 1994.
10. Kenins P. Identification of the unmyelinated sensory nerves which evoke plasma extravasation in response to antidromic stimulation. Neurosci Lett. 1981;25:137-141.
11. Sakamoto T, Barnes PJ, Chung KF. Effect of CP-96,345, a non-peptide receptor antagonist, against substance P-induced, bradykinin-induced and allergen-induced airway microvascular leakage and bronchoconstriction in the guinea pig. Eur J Pharmacol. 1993;231:31-38.
12. Peretti M, Ahluwalia A, Flower RJ, Manzini S. Endogenous tachykinins play a pivotal role in IL-1-induced neutrophil accumulation: involvement of NK-1 receptors. Immunology. 1993;80:73-77.
13. Mentlein R, Roos T. Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells. Peptides. 1996;17:709-720.
14. Di Marco E, Marchisio PC, Bondanza S, Franzi AT, Cancedda R, De Luca M. Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem. 1991;266:21718-21722.
15. Pernow J. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control. Acta Physiol Scand Suppl. 1988;568:1-56.
16. Saria A. Neuropeptide. Hautarzt. 1992;43:745-752.
17. Trantor IR, Messer HH, Birner R. The effects of neuropeptides (calcitonin gene-related peptide and substance P) on cultured human pulp cells. J Dent Res. 1995;74:1066-1071.
18. Maggi CA, Patacchini R, Rovero P, Giachetti A. Tachykinin receptors and tachykinin receptor antagonists. J Auton Pharmacol. 1993;13:23-93.
19. Krause JE, Chirgwin JM, Carter MS, Xu ZS, Hershey AD. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc Natl Acad Sci U S A. 1987;84:881-885.
20. Mägert HJ, Heitland A, Rose M, Forssmann WG. Nucleotide sequence of the rabbit r-preprotachykinin I cDNA. Biochem Biophys Res Commun. 1993;195:128-131.
21. Lundberg JM. Pharmacology of cotransmission in the autonomic nervous system: intergrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev. 1996;48:113-178.
22. Pernow B. Substance P. Pharmacol Rev. 1983;35:85-141.
23. Barber R, Vaughn J, Slemmon J, Salvaterra P, Roberts E, Leeman S. The origin, distribution and synaptic relationship of substance P axons in rat spinal cord. J Comp Neurol. 1979;184:331-351.
24. Maggio JE. Tachykinins. Annu Rev Neurosci. 1988;11:13-28.
25. Quirion R, Dam TV. Multiple neurokinin receptors: recent developments. Regul Peptides. 1988;22:18-25.
26. Krause JE, Takeda Y, Hershey AD. Structure, functions, and mechanisms of substance P receptor action. J Invest Dermatol. 1992;98(6 suppl):2S-7S.
27. MacDonald SG, Dumas JJ, Boyd ND. Chemical cross-linking of the substance P (NK-1) receptor to the a subunits of the G proteins Gq and G11. Biochemistry. 1996;35:2909-2916.
28. Bolton T, Clapp L. Endothelial-dependent relaxant actions of carbachol and substance P in arterial smooth muscle. Br J Pharmacol. 1986;87:713-715.
29. Hökfelt T, Kellerth J, Nilsson G, Pernow B. Substance P: localization in the central nervous system and in some primary sensory neurones. Science. 1975;190:889-890.
30. Devillier P, Regoli D, Asseraf A, Descours B, Marsac J, Renoux M. Histamine release and local responses of rat and human skin to substance P and other mammalian tachykinins. Pharmacology. 1986;32:340-347.
31. Lundberg JM, Saria A, Brodin E, Rosell S, Folkers K. A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. Proc Natl Acad Sci U S A. 1983;80:1120-1124.
32. Baluk P, Bowden JJ, Lefevre PL, McDonald DM. Increased expression of substance P (NK1) receptors on airway blood vessels of rats with Mycoplasma pulmonis infection. Am J Respir Crit Care Med. 1994;151:A719-A729.
33. Bowden JJ, Garland AM, Baluk P, et al. Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation. Proc Natl Acad Sci U S A. 1994;91:8964-8968.
34. Ansel JC, Kaynard AH, Armstrong CA, Olerud J, Bunnett N, Payan D. Skin-nervous system interactions. J Invest Dermatol. 1996;106:198-204.
35. Bowden JJ, Baluk P, Lefevre PM, Vigna SR, McDonald DM. Substance P (NK1) receptor immunoreactivity on endothelial cells of the rat tracheal mucosa. Am J Physiol. 1996;270 (3 pt 1):L404-L414.
36. Emerson RB. Posttranscriptional regulation of calcitonin-gene-related peptide (CGRP) mRNA. In: Geppetti P, Holzer P, eds. Neurogenic Inflammation. Boca Raton, Fla: CRC Press Inc; 1996:15-20.
37. Emerson RB, Hedjran F, Yeakley JM, Guise JW, Rosenfeld MG. Alternative production of calcitonin and CGRP mRNA is regulated at the calcitonin-specific splice acceptor. Nature. 1989;341:76-80.
38. Van Valen F, Piechot G, Jurgens H. Calcitonin gene-related peptide (CGRP) receptors are linked to cyclic adenosine monophosphate production in SK-N-MC human neuroblastoma cells. Neurosci Lett. 1990;119:195-198.
39. Yamaguchi A, Chiba T, Yamatani T, et al. Calcitonin gene-related peptide stimulates adenylate cyclase activation via a guanine nucleotide-dependent process in rat liver plasma membranes. Endocrinology. 1988;123:2591-2596.
40. Hall JM, Brain SD. Pharmacology of calcitonin gene-related peptide. In: Geppetti P, Holzer P, eds: Neurogenic Inflammation. Boca Raton, Fla: CRC Press Inc; 1996:101-106.
41. Poyner DR. Pharmacology of receptors for calcitonin gene-related peptide and amylin. Trends Pharmacol Sci. 1995;16:424-428.
42. Kapas S, Clark AJ. Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor. Biochem Biophys Res Commun. 1995;217:832-838.
43. Luebke AE, Dahl GP, Roos BA, Dickerson IM. Identification of a protein that confers calcitonin gene-related peptide responsiveness to oocytes by using a cystic fibrosis transmembrane conductance regulator assay. Proc Natl Acad Sci U S A. 1996;93:3455-3460.
44. Navarro X, Verdu E, Wendelschafer-Crabb G, Kennedy WR. Innervation of cutaneous structures in the mouse hind paw: a confocal microscopy immunohistochemical study. J Neurosci Res. 1995;41:111-120.
45. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I. Calcitonin gene-related peptide is a potent vasodilatator. Nature. 1985;313:54-56.
46. Gamse R, Saria A. Potentiation of tachykinin-induced plasma protein extravasation by calcitonin-gene-related peptide. Eur J Pharmacol. 1985;114:61-66.
47. Louis SM, Jamieson A, Russell NJW, Dockray GJ. The role of substance P and calcitonin gene-related peptide in neurogenic plasma extravasation and vasodilatation in the rat. Neurosci ence. 1989;32:581-586.
48. Bruce NA. über die Beziehung der sensiblen Nervenendigungen zum Entzündungsvorgang. Arch Exp Path Pharmak. 1910;63:424-433.
49. Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol. 1985;135:755-763.
50. Knighton DR, Fiegel VD. Regulation of cutaneous wound healing by growth factors and the microenvironment. Invest Radiol 1991;26:604-611.
51. Simpson DW, Ross R. The neutrophilic leukocyte in wound repair: a study with anti-neutrophil serum. J Clin Invest. 1972;51:2009-2023.
52. Thureson-Klein A, Hedqvist P, Öhlen A, Raud J, Lindbom L. Leukotriene B4, platelet-activating factor and substance P as mediators of acute inflammation. Pathol Immunopathol Res. 1987;6:190-206.
53. Zimmerman BJ, Anderson DC, Granger DN. Neuropeptides promote neutrophil adherence to endothelial cell monolayers. Am J Physiol. 1992;263(5 pt 1):G678-G682.
54. Greeno EW, Mantyh P, Vercellotti GM, Moldow CF. Functional neurokinin 1-receptors for substance P are expressed by human vascular endothelium. J Exp Med. 1993;177:1269-1276.
55. Baluk P, Bertrand C, Geppetti P, McDonald DM, Nadel JA. NK1 receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea. Am J Physiol. 1995;268(2 pt 1)L263-L269.
56. Carolan EJ, Casale TB. Effects of neuropeptides on neutrophil migration through noncellular and endothelial barriers. J Allergy Clin Immunol. 1993;92:589-598.
57. Marasco WA, Showell HJ, Becker EL. Substance P binds to the formylpeptide receptor on the rabbit neutrophil. Biochem Biophys Res Commun. 1981;99:1065-1072.
58. Roch-Arveiller M, Regoli D, Chanaud B, et al. Tachykinins: effects on motility and metabolism of rat polymorphonuclear leukocytes. Pharmacology. 1986;33:266-273.
59. Bodesson L, Norolind K, Liden S, Gafvelin G, Theodorsson E, Mutt V. Dual effects of vasoactive intestinal peptide (VIP) on leucocyte migration. Acta Physiol Scand. 1991;141:477-481.
60. Rabier M, Damon M, Chanez P. Neutrophil chemotactic activity of PAF, histamine and neuromediators in bronchial asthma. J Lipid Mediat Cell Signal. 1991;4:265-275.
61. Niedermuhlbichler M, Wiedermann C. Suppression of superoxide release from human monocytes by somatostatin-related peptides. Regul Peptides. 1992;41:39-47.
62. Nong Y-H, Titus RG, Ribeiro JMC, Remold HG. Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol. 1989;143:45-49.
63. Fox FE, Kubin M, Cassin M, et al. Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12. J Invest Dermatol. 1997;108:43-48.
64. Peluso G, Petillo O, Melone MAB, Mazzarella G, Ranieri M, Tajana GF. Modulation of cytokine production in activated human monocytes by somatostatin. Neuropeptides. 1996;30:443-451.
65. Hartung H-P, Wolters K, Toyka KV. Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J Immunol. 1986;136:3856-3863.
66. Lotz M, Vaughan JH, Carson DA. Effects of neuropetides on production of inflammatory cytokines by human monocytes. Science. 1988;241:1218-1220.
67. Rameshwar P, Ganea D, Gascon P. Induction of IL-3 and granulocyte-macrophage colony-stimulating factor by substance P in bone marrow cells is partially mediated through the release of IL-1 and IL-6. J Immunol. 1994;152:4044-4054.
68. Bahl AK, Foreman JC. Stimulation and release of interleukin-1 from peritoneal macrophages of the mouse. Agents Actions. 1994;42:154-158.
69. Lieb K, Fiebich BL, Busse-Grawitz M, Hüll M, Berger M, Bauer J. Effects of substance P and selected other neuropeptides on the synthesis of interleukin-1β and interleukin-6 in human monocytes: a re-examination. J Neuroimmunol. 1996;67:77-81.
70. Chancellor-Freeland C, Zhu GF, Kage R, Beller DI, Leeman SE, Black PH. Substance P and stress-induced changes in makrophages. Ann N Y Acad Sci. 1994;771:472-484.
71. Jeurissen F, Kavelaars A, Korstjens M, et al. Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase. J Immunol. 1994;152:2987-2994.
72. Kavelaars A, Broeke D, Jeurissen F, et al. Activation of human monocytes via a non-neurokinin substance P receptor that is coupled to Gi protein, calcium, phospholipase D, MAP kinase, and IL-6 production. J Immunol. 1994;153:3691-3699.
73. Fishel RS, Barbul A, Beschorner WE, Wasserkrug HL, Efron G. Lymphocyte participation in wound healing: morphologic assessment using monoclonal antibodies. Ann Surg. 1987;206:25-29.
74. Vishwanath R, Mukherjee R. Substance P promotes lymphocyte endothelial cell adhesion preferentially via LFA 1/ICAM 1 interactions. J Neuroimmunol. 1996;71:163-171.
75. Payan DG, Goetzl EJ. Modulation of lymphocyte function by sensory neuropeptides. J Immunol. 1985;135(2 suppl):783S-786S.
76. Stanisz AM, Befus D, Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunglobulin synthesis and proliferation by lymphocytes from Peyeris patches, mesenteric lymph nodes, and spleen. J Immunol. 1986;136:152-156.
77. Teresi S, Boudard F, Bastide M. Effect of calcitonin gene-related peptide and vasoactive intestinal peptide on murine CD4 and CD8 T cell proliferation. Immunol Lett. 1996;50:105-113.
78. Xin Z, Tang H, Ganea D. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. J Neuroimmunol. 1994;54:59-68.
79. Calvo C-F, Chavanel G, Senik A. Substance P enhances IL-2 expression in activated human T cells. J Immunol. 1992;148:3498-3504.
80. Nio DA, Moylan RN, Roche JK. Modulation of T lymphocyte function by neuropeptides. J Immunol. 1993;150:5281-5288.
81. Czarnetzki BM. Mechanisms and mediators in urticaria. Semin Dermatol. 1987;6:272-276.
82. Wershil BK, Mekori YA, Murakami T, Galli SJ. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin: demonstration of the role of mast cells using mast cell-deficient mice locally reconstituted with cultured mast cells. J Immunol. 1987;139:2605-2614.
83. Burd PR, Rogers HW, Gordon JR, et al. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med. 1989;170:245-257.
84. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordon RP, Paul WE. Mast cell lines produce lymphokines in response to cross linkage of Fc∈RI or calcium ionophores. Nature. 1989;339:64-67.
85. Goetzl EJ, Chernov T, Renold F, Payan DG. Neuropeptide regulation of the expression of immediate hypersensitivity. J Immunol. 1985;135(2 suppl):802S-805S.
86. Muller S, Weihe E. Interrelation of peptidergic innervation with mast cells and ED1-positive cells in rat thymus. Brain Behav Immun. 1991;5:55-72.
87. Newson B, Dahlstrom A, Enerback L, Ahlman H. Suggestive evidence for a direct innervation of mucosal mast cells: an electron microscopic study. Neuroscience. 1983;10:565-570.
88. Ratzlaff RE, Cavanaugh VJ, Miller GW, Oakes SG. Evidence of a neurogenic component during IgE-mediated inflammation in mouse skin. J Neuroimmunol. 1992;41:89-96.
89. Stead RH, Tomioka M, Quinoez G, Simon GT, Felten SY, Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci U S A. 1987;84:2975-2979.
90. Cross LJM, Beck-Sickinger AG, Bienert M, et al. Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues. Br J Pharmacol. 1996;117:325-332.
91. Ebertz JM, Hirschman CA, Kettlekamp NS, Uno H, Hanifin JM. Substance P induced histamine release in human cutaneous mast cells. J Invest Dermatol. 1987;88:682-685.
92. Stewart MJ, Emery DL, McClure SJ, Bendixen T. The effects of four neuropeptides on the degranulation of mucosal mast cells from sheep. Immunol Cell Biol. 1996;74:255-257.
93. Ansel JC, Brown JR, Payan DG, Brown MA. Substance P selectively activates TNF-α gene expression in murine mast cells. J Immunol. 1993;150:4478-4485.
94. Corvera CU, Dery O, McConalogue KM, et al. Mast cell tryptase regulates colonic myocytes through proteinase-activated receptor-2. J Clin Invest. 1997;100:1383-1393.
95. Coughlin SR. Protease-activated receptors start a family [comment]. Proc Natl Acad Sci U S A. 1994;91:9200-9202.
96. Corvera UC, McConalogue K, Gamp P, Caughey GH, Bunnett NW. Proteinase activated receptors (PARS): myenteric neurons: activators thrombinmast cell tryptase [abstract G4653]. Dig Wk Gasteroenterol. 1998;114(pt 2):A1137.
97. Bunnett NW. The role of neuropeptides in regulating airway function: postsecretory metabolism of peptides. Am Rev Respir Dis. 1987;136(6 suppl):S27-S34.
98. Bathon JM, Proud D, Mizutani S, Ward PE. Cultured human synovial fibroblasts rapidly metabolize kinins and neuropeptides. J Clin Invest. 1992;90:981-991.
99. Kenny AJ, Hooper NM. Peptidases involved in the metabolism of bioactive peptides. In: Henrickson JH, ed. Degradation of Bioactive Substances: Physiology and Pathophysiology. Boca Raton, Fla: CRC Press Inc; 1991:47-49.
100. Russell JS, Chi H, Lantry LE, Stephens RE, Ward PE. Substance P and neurokinin A metabolism by cultured human skeletal muscle myocytes and fibroblasts. Peptides. 1996;17:1397-1403.
101. Shipp MA, Stefano GB, DiAdamio L, et al. Down-regulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11. Nature. 1990;347:394-396.
102. Borson D, Brokaw J, Sekizawa K, McDonald D, Nadel J. Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections. J Appl Physiol. 1989;66:2653-2658.
103. Hwang L, Leichter R, Okamoto A, Payan D, Collins S, Bunnett N. Downregulation of neutral endopeptidase (EC 3.4.24.11) in the inflamed rat intestine. Am J Physiol. 1993;264:G735-G743.
104. Umeno E, Nadel J, Huang H-T, McDonald D. Inhibition of neutral endopeptidase potentiates neurogenic inflammation in the rat trachea. J Appl Physiol. 1989;66:2647-2652.
105. Borson D, Gruenert D. Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. Am J Physiol. 1990;260: L83-L89.
106. Ihara H, Nakanishi S. Selective inhibition of expression of the substance P receptor mRNA in pancreatic acinar AR42J cells by glucocorticoids. J Biol Chem. 1990;265:22441-22445.
107. Jackman HL, Tan F, Tamei H, et al. A peptidase in human platelets that deamidates tachykinins. J Biol Chem. 1990;265:11265-11272.
108. Nielsen OH, Rask-Madsen J. Mediators of inflammation in chronic bowel disease. Scand J Gastroenterol Suppl. 1996;216:149-159.
109. Bertrand C, Nadel JA, Yamawaki I, Geppetti P. Role of kinins in the vascular extravasation evoked by antigen and mediated by tachykinins in guinea pig trachea. J Immunol. 1993;151:4902-4907.
110. Ricciardolo FLM, Nadel JA, Bertrand C, Yamawaki I, Chan B, Geppetti P. Tachykinins and kinins in antigen-evoked plasma extravasation in guinea pig nasal mucosa. Eur J Pharmacol. 1994;261:127-132.
111. Geppetti P, Bertrand C, Ricciardolo FML, Nadel JA. New aspects on the role of kinins in neurogenic inflammation. Can J Physiol Pharmacol. 1995;73:843-847.
112. Dudel J, Menzel R, Schmidt RF, eds. Neurowissenschaften: Vom Molekül zur Kognition. Berlin, Germany: Springer-Verlag: 1996.
113. Przewlocki R, Hassan AHS, Lason W, Epplen C, Herz A, Stein C. Gene expression and localization of opioid peptides in immune cells in inflamed tissue: functional role in antinociception. Neuroscience. 1992;48:491-500.
114. Prystowsky MJ, Angeletti RH. Preproenkephalin mRNA in T-cells, macrophages, and mast cells. J Neurosci Res. 1987;18:82-87.
115. Stein C, Hassan AHS, Przewlocki R, Gramsch C, Peter K, Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci U S A. 1990;87:5953-5959.
116. Zurawski G, Benedik M, Kamb BJ, Abrams JS, Zurawski SM, Lee FD. Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science. 1986;232:772-774.
117. Gilmore W, Weiner LP. β-endorphin enhances interleukin-2 (IL-2) production in murine lymphocytes. J Neuroimmunol. 1988;18:125-138.
118. Stefano GB. Role of opioid neuropeptides in immunoregulation. Prog Neurobiol. 1989;33:149-159.
119. Sibinga NES, Goldstein A. Opioid peptides and opioid receptors in cells of the immune system. Annu Rev Immunol. 1988;6:219-249.
120. Van den Berg P, Dobber R, Ralal S, Ramlal S, Rozing J, Nagelkerken L. Role of opioid peptides in the regulation of cytokine production by murine CD4+ T cells. Cell Immunol. 1994;154:109-122.
121. Levi-Montalcini R. The nerve growth factor: thirty-five years later. EMBO J. 1987;6:1145-1154.
122. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurones. Nature. 1989;337:362-364.
123. Rich KM, Yip HK, Osbourne PA, Schmidt RF, Johnson EM. Role of nerve growth factor in the adult dorsal root ganglia neuron and its responses to injury. J Comp Neurol. 1984;230:110-118.
124. Chao MV. Neurotrophin receptors: a window into neural differentiation. Neuron. 1992;9:583-593.
125. Glass DJ, Yancopopoulus GD. The neurotrophins and their receptors. Trends Cell Biol. 1993;3:262-268.
126. Kaplan D, Hempstead B, Martin-Zanca D, Chao M, Parada L. The trk prooncogene product: a signal transducing receptor for nerve growth factor. Science. 1991;252:554-558.
127. Rich KM, Luszczynski JR, Osbourne PA, Johnson EM. Nerve growth factor protects adult sensory neurones from cell death and atrophy caused by nerve injury. J Neurocytol. 1987;16:261-268.
128. Stockel K, Schwab M, Thoenen H. Specificity of retrograde transport of nerve growth factor (NGF) in sensory neurones: a biochemical and morphological study. Brain Res. 1975;89:1-14.
129. Tron VA, Coughlin MD, Jang DE, Stanisz J, Sauder DN. Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J Clin Invest. 1990;85:1085-1089.
130. Brown MC, Perry VH, Lunn ER, Gordon S, Heumann R. Macrophage dependence of peripheral sensory nerve regeneration: possible involvement of nerve growth factor. Neuron. 1991;6:359-370.
131. Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A. 1994;91:3739-3743.
132. McMahon SB. NGF as a mediator of inflammatory pain. Philos Trans R Soc Lond B Biol Sci 1996;351:431-440.
133. Santambrogio L, Benedetti M, Chao MV, et al. Nerve growth factor production by lymphocytes. Immunology. 1994;153:4888-4898.
134. Thoenen H, Bandtlow C, Heumann R, Lindholm M, Rohrer H. Nerve growth factor: cellular localization and regulation of synthesis. Trends Neurosci. 1988;17:432-438.
135. Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience. 1992;49:693-698.
136. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ. Contribution of interleukin-1β to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol. 1995;115:1265-1275.
137. Weskamp G, Otten U. An enzyme-linked immunoassay for nerve growth factor: a tool for studying regulatory mechanisms involved in NGF production in brain and peripheral tissue. J Neurochem. 1987;48:1779-1786.
138. Bischoff SC, Dahinden CA. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood. 1992;79:2662-2669.
139. Horigome E, Pryor JC, Bullock ED, Johnson EM. Mediator release from mast cells by nerve growth factor: neutrophin specificity and receptor mediation. J Biol Chem. 1993;268:14881-14887.
140. Pearce FL, Thompson HL. Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol. 1986;372:379-393.
141. Amann R, Sirinathsingji DJ, Donnerer J, Liebmann I, Schuligoi R. Stimulation by nerve growth factor-of neuropeptide synthesis in the adult rat in vivo: bilateral response to unilateral intraplantar injections. Neurosci Lett 1996;203:171-174.
142. Kashiba H, Ueda Y, Senba E. Coexpression of preprotachykinin-A, α-calcitonin gene-related peptide, somatostatin, and neurotrophin receptor family messenger RNAs in rat dorsal root ganglion neurons. Neuroscience. 1996;70:179-189.
143. Leslie TA, Emson PC, Dowd PM, Woolf CJ. Nerve growth factor contributes to the up-regulation of growth-associated protein 43 and preprotachykinin A messenger RNAs in primary sensory neurons following peripheral inflammation. Neuroscience. 1995;67:753-761.
144. Verge VMK, Richardson PM, Wiesenfeld-Hallin Z, Hökfelt T. Differential influence of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons. J Neurosci. 1995;15:2081-2096.
145. MacArthur L, Eiden L, Neuropeptide genes: targets of activity-dependent signal transduction. Peptides. 1996;17:721-728.
146. Aldskogius H, Hermanson A, Jonsson C-E. Reinnervation of experimental superficial wounds in rats. Plast Reconstr Surg. 1986;79:595-599.
147. Aoki M, Tamai K, Saotome K. Substance P- and calcitonin gene-related peptide-immunofluorescent nerves in the repair of experimental bone defects. Int Orthop. 1994;18:317-324.
148. Kishimoto S. The regeneration of substance P- containing nerve fibers in the process of burn wound healing in the guinea pig skin. J Invest Dermatol. 1984;83:219-223.
149. Kjartansson J, Dalsgaard C. Calcitonin gene-related peptide increases survival of a musculocutaneous critical flap in the rat. Eur J Pharmacol. 1987;142:355-358.
150. Kjartansson J, Dalsgaard C, Jonsson C. Decreased survival of experimental critical flaps after sensory denervation with capsaicin. Plast Reconstr Surg. 1987;79:218-220.
151. McGovern UB, Jones KT, Sharpe GR. Intracellular calcium as a second messenger following growth stimulation of human keratinocytes. Br J Dermatol. 1995;132:892-896.
152. Tanaka T, Danno K, Ikai K, Imamura S. Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol. 1988;90:399-401.
153. Wollina U, Bonnekoh B, Klinger R, Wetzker R, Mahrle G. Vasoactive intestinal peptide (VIP) acting as a growth factor for human keratinocytes. Neuroendocrinol Lett. 1992;14:21-32.
154. Nilsson J, von Euler AM, Dalsgaard C-J. Stimulation of connective cell growth by substance P and substance K. Nature. 1985;315:61-63.
155. Haegerstrand A, Dalsgaard C-J, Jonzon B, Larsson O, Nilsson J. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci U S A. 1990;87:3299-3303.
156. Fan T-PD, Hu D-E. Modulation of angiogenesis by inflammatory polypeptides. Int J Radiat Biol. 1991;60:71-76.
157. Fan T-PD, Hu D-E, Guard S, Gresham GA, Watling KJ. Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Br J Pharmacol. 1993;110:43-49.
158. Ziche M, Morbidelli L, Pacini M, Geppetti P, Alessandri G, Maggi CA. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res. 1990;40:264-278.
159. Wiedermann CJ, Auer B, Sitte B, Reinisch N, Schratzberger P, Kähler CM. Induction of endothelial cell differentiation into capillary-like structures by substance P. Eur J Pharmacol. 1996;298:335-338.
160. Kähler CM, Herold M, Reinisch N, Wiedermann CJ. Interaction of substance P with epidermal growth factor and fibroblast growth factor in cyclooxygenase-dependent proliferation of human skin fibroblasts. J Cell Physiol. 1996;166:601-608
161. Ziche M, Morbidelli L, Pacini M, Dolara P, Maggi CA. NK1-receptors mediate the proliferative response of human fibroblasts to tachykinins. Br J Pharmacol. 1990;100:11-14.
162. Lewis T, Marvin H. Observations relating to vasodilatation arising from antidromic impulses, to herpes zoster and trophic effects. Hearts. 1927;14:27-46.
163. Lusthaus S, Shoshan S, Benmeir P, Livoff A, Ashur H, Vardy D. Effect of denervation on incision wound scars in rabbits. J Geriatr Dermatol. 1993;1:11-14.
164. Gallar J, Pozo M, Rebello I, Belmonte C. Effects of capsaicin on corneal wound healing. Invest Ophthalmol Vis Sci. 1990;31:1968-1974.
165. Maggi CA, Borsini F, Santicioli P, et al. Cutaneous lesions in capsaicin-pretreated rats: a trophic role of capsaicin-sensitive afferents? Naunyn Schmiedebergs Arch Pharmacol. 1987;336:538-543.
166. Jonsson C-E, Brodin E, Dalsgaard C-J, Haegerstrand A. Release of substance P-like immunoreactivity in dog paw lymph after scalding injury. Acta Physiol Scand. 1986;126:21-24.
167. Grönblad M, Korkala O, Konttinen Y, Kuokkanen H, Liesi P. Immunoreactive neuropeptides in nerves in ligamentous tissue: an experimental neuroimmunohistochemical study. Clin Orthopaed Relat Res. 1991;265:291-296.
168. Rusanen M, Korkala O, Grönblad M, Partanen S, Nederström A. Evolution of substance P immunofluorescent nerves in callus tissue during fracture healing. J Trauma. 1987;27:1340-1343.
169. Senapati A, Anand P, McGregor GP, Ghatei MA, Thompson RPH, Bloom SR. Depletion of neuropeptides during wound healing in rat skin. Neurosci Lett. 1986;71:101-105.
170. Spevak S, Shekhter A, Hilse H, Oehme P, Soloveva A. Aspects of wound healing in spontaneous hypertensive rats: the effect of morphine, substance P and its fragments SP1-4. Biull Eksp Biol Med. 1989;107:729-743.